Illumina Grows Clinical IVD Portfolio with Introduction of NextSeq™ 550Dx System and Expanded Use of MiSeq™Dx System

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today the introduction of its NextSeq™ 550Dx instrument, the company’s second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system. The company also announced that the intended use for the MiSeq™Dx instrument has been updated to include the use of DNA libraries generated from formalin-fixed paraffin embedded (FFPE) tissues,... Read more

Fabric Genomics Announces Expanded Oncology Solution, Extending Somatic Cancer Analysis to Clinical Labs

Solution enables clinical labs that perform cancer NGS testing to quickly convert genomic insights to targeted therapies November 15, 2017 05:00 AM Pacific Standard Time SALT LAKE CITY–(BUSINESS WIRE)–This week, at the Association for Molecular Pathology (AMP) Annual Meeting, Fabric Genomics will announce its expanded somatic cancer solution which provides seamless genomic analysis and clinical reporting to... Read more

Promega Maxwell® Modular Automated Nucleic Acid Preparation System Allows Customized Workflows for Labs of All Sizes

MADISON, WI USA (November 14, 2017) A modular automated liquid handling and purification system developed by Promega Corporation for its Maxwell® nucleic acid preparation offersgives labs new found flexibility compared to large all-in-one instruments. The configurable system, which launched this week, works with existing Promega Maxwell® RSC instruments with a software upgrade and introduces two new... Read more

QIAGEN’s GeneReader NGS System delivers accuracy and ease of use for clinical research in oncology

Hilden, Germany, and Germantown, Maryland, November 14, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new studies highlighting the outstanding analytical performance and ease of use of the GeneReader NGS System, the world’s first complete Sample to Insight solution for next-generation sequencing. The studies are being presented this week at the... Read more

Leading Pathologists to Showcase First Case Studies with Oncomine Dx Target Test at Association for Molecular Pathology Annual Meeting

Leading Pathologists to Showcase First Case Studies with Oncomine Dx Target Test at Association for Molecular Pathology Annual Meeting Thermo Fisher Scientific customers also highlight their latest research advancements in solid tumor profiling and liquid biopsy analysis during corporate workshops CARLSBAD, Calif. and SALT LAKE CITY, Nov. 14, 2017 /PRNewswire/ — Advances in next-generation sequencing (NGS)... Read more

Canopy Biosciences Launches CRISPR Complete Gene Editing Kits

ST. LOUIS, Nov. 13, 2017 /PRNewswire/ — Canopy Biosciences™, LLC, a provider of technologies for gene editing and personalized medicine, announced today that it has launched CRISPR Complete Gene Editing Kits. The CRISPR Complete Kits are the most comprehensive CRISPR kits available, including everything a researcher needs to perform gene editing with the CRISPR-Cas9 system.... Read more

New CRISPR Kits Simplify Gene Editing

Canopy Biosciences launches CRISPR Complete Gene Editing Kits ST. LOUIS, Nov. 13, 2017 /PRNewswire/ — Canopy Biosciences™, LLC, a provider of technologies for gene editing and personalized medicine, announced today that it has launched CRISPR Complete Gene Editing Kits. The CRISPR Complete Kits are the most comprehensive CRISPR kits available, including everything a researcher needs to perform gene... Read more

GNA Biosolutions Reveals New Ultrafast PCR Platform at Medica

Published on November 13, 2017. Groundbreaking nucleic acid detection technology using nanomaterials DUESSELDORF, Germany, November 13 – GNA Biosolutions GmbH, a molecular technology company based in Martinsried, Germany, today announced the launch of Pharos V8, the world’s first Laser PCR® platform. Pharos V8, an ultrafast PCR instrument for in vitro research use, will be showcased at the Medica Trade Fair... Read more

SnapGene and Synbio Technologies Partner to Streamline Construct Design and Synthesis

SnapGene customers can now order synthetic biology constructs directly from the software through Synbio Technologies. November 13, 2017 07:00 AM Pacific Standard Time CHICAGO–(BUSINESS WIRE)–Synbio Technologies and GSL Biotech have finalized a non-exclusive agreement allowing customers of GSL Biotech’s “SnapGene” software to order constructs directly from Synbio Technologies after having designed them in SnapGene. GSL Biotech developed SnapGene... Read more

ERS Genomics and Cellecta, Inc. Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Tools and Services

DUBLIN, Ireland, and Mountain View, CA, November 10, 2017 – ERS Genomics Ltd. and Cellecta, Inc. announced today a non-exclusive license agreement to provide Cellecta with worldwide access to ERS Genomics’ CRISPR/Cas9 genome editing intellectual property for use in informing research tools and services. ERS Genomics holds rights to the foundational CRISPR/Cas9 patent portfolio from Dr. Emmanuelle Charpentier, who... Read more